Recent advances of pharmaceutical crystallization theories
J Weng, Y Huang, D Hao, Y Ji - Chinese Journal of Chemical Engineering, 2020 - Elsevier
… of crystallization is still rare, and the control of crystallization … pharmaceutical crystallization
filed and review advances in the research on the theories of pharmaceutical crystallization …
filed and review advances in the research on the theories of pharmaceutical crystallization …
Recent Advances in the Application of Machine Learning to Crystal Behavior and Crystallization Process Control
M Lu, S Rao, H Yue, J Han, J Wang - Crystal Growth & Design, 2024 - ACS Publications
… pharmaceuticals and advancements in material science. To anticipate crystal behavior and
pinpoint effective crystallization … model over a first-principles model is that crystallization is a …
pinpoint effective crystallization … model over a first-principles model is that crystallization is a …
Recent progress in continuous crystallization of pharmaceutical products: precise preparation and control
… crystalline pharmaceutical products, so selecting a suitable continuous crystallizer is a
prerequisite for precise control of the pharmaceutical-related crystalline … ) presented first-principles …
prerequisite for precise control of the pharmaceutical-related crystalline … ) presented first-principles …
[HTML][HTML] Application of PAT-based feedback control approaches in pharmaceutical crystallization
… Based on the current progress of pharmaceutical crystallization process control, this paper
… of industrial crystallization process control through process analysis technology and control …
… of industrial crystallization process control through process analysis technology and control …
First‐principles modeling of molecular crystals: structures and stabilities, temperature and pressure
J Hoja, AM Reilly, A Tkatchenko - Wiley Interdisciplinary …, 2017 - Wiley Online Library
… that find applications as pharmaceuticals, explosives, organic … crystalline phase diagram
calculated from first principles. This … In addition, we would like to explicitly include crystallization …
calculated from first principles. This … In addition, we would like to explicitly include crystallization …
Application of model-free and model-based quality-by-control (QbC) for the efficient design of pharmaceutical crystallization processes
B Szilagyi, A Eren, JL Quon… - … Growth & Design, 2020 - ACS Publications
… This study presented a comprehensive description for the application of the quality-by-control
(QbC) framework for pharmaceutical crystallization design. QbC has the potential to …
(QbC) framework for pharmaceutical crystallization design. QbC has the potential to …
Mechanisms and control of impurities in continuous crystallization: a review
C Darmali, S Mansouri, N Yazdanpanah… - Industrial & …, 2018 - ACS Publications
… fine chemicals and the pharmaceutical and food industries. It is important to strategically …
the purity control in the batch process with the continuous approach to the crystallization. The …
the purity control in the batch process with the continuous approach to the crystallization. The …
Polymorphic control and scale-up strategy for antisolvent crystallization using a sequential supersaturation and direct nucleation control approach
… direct design approach for crystallization processes was implemented using the novel
Quality-by-Control (… Crystallization is a key unit operation in the pharmaceutical industry and often …
Quality-by-Control (… Crystallization is a key unit operation in the pharmaceutical industry and often …
Polymorphic control and scale-up strategy for antisolvent crystallization using direct nucleation control
… of direct design and quality-by-control (QbC) was applied and investigated using direct
nucleation control (… Crystallization is a key unit operation in the pharmaceutical industry, often …
nucleation control (… Crystallization is a key unit operation in the pharmaceutical industry, often …
[图书][B] Pharmaceutical crystals: science and engineering
T Li, A Mattei - 2018 - books.google.com
… three-dimensional (3D) crystal structure, yet it is not given that a drug candidate entering
into pharmaceutical development will crystallize, let alone in a form that is amenable to …
into pharmaceutical development will crystallize, let alone in a form that is amenable to …